Pathstone Family Office’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $20.3K | Hold |
10,000
| – | – | ﹤0.01% | 1644 |
|
|
2023
Q2 | $23K | Hold |
10,000
| – | – | ﹤0.01% | 1223 |
|
|
2023
Q1 | $30.3K | Sell |
10,000
-10,000
| -50% | -$30.3K | ﹤0.01% | 1164 |
|
|
2022
Q4 | $57.6K | Hold |
20,000
| – | – | ﹤0.01% | 1457 |
|
|
2022
Q3 | $38.1K | Buy |
20,000
+10,000
| +100% | +$19.1K | ﹤0.01% | 1438 |
|
|
2022
Q2 | $27.1K | Hold |
10,000
| – | – | ﹤0.01% | 1027 |
|
|
2022
Q1 | $30K | Buy |
+10,000
| New | +$30K | ﹤0.01% | 944 |
|